Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Myeloid-Derived Suppressor Cell Differentiation in Cancer: Transcriptional Regulators and Enhanceosome-Mediated Mechanisms.
Front Immunol. 2021 Jan 14;11:619253. doi: 10.3389/fimmu.2020.619253. eCollection 2020.
Front Immunol. 2021.
PMID: 33519825
Free PMC article.
Review.
c-Rel-dependent monocytes are potent immune suppressor cells in cancer.
Li T, Bou-Dargham MJ, Fultang N, Li X, Pear WS, Sun H, Chen YH.
Li T, et al. Among authors: fultang n.
J Leukoc Biol. 2022 Oct;112(4):845-859. doi: 10.1002/JLB.1MA0422-518RR. Epub 2022 Jun 13.
J Leukoc Biol. 2022.
PMID: 35694784
Free PMC article.
Item in Clipboard
Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements.
Illendula A, Fultang N, Peethambaran B.
Illendula A, et al. Among authors: fultang n.
Oncol Rep. 2020 Sep;44(3):1013-1024. doi: 10.3892/or.2020.7681. Epub 2020 Jul 7.
Oncol Rep. 2020.
PMID: 32705280
Free PMC article.
Item in Clipboard
ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1.
Fultang N, Illendula A, Lin J, Pandey MK, Klase Z, Peethambaran B.
Fultang N, et al.
Sci Rep. 2020 Feb 4;10(1):1821. doi: 10.1038/s41598-020-58864-0.
Sci Rep. 2020.
PMID: 32020017
Free PMC article.
Item in Clipboard
Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity.
Fultang N, Illendula A, Chen B, Wu C, Jonnalagadda S, Baird N, Klase Z, Peethambaran B.
Fultang N, et al.
PLoS One. 2019 May 31;14(5):e0217789. doi: 10.1371/journal.pone.0217789. eCollection 2019.
PLoS One. 2019.
PMID: 31150511
Free PMC article.
Item in Clipboard
Regulation of cancer stem cells in triple negative breast cancer.
Fultang N, Chakraborty M, Peethambaran B.
Fultang N, et al.
Cancer Drug Resist. 2021 Jun 19;4(2):321-342. doi: 10.20517/cdr.2020.106. eCollection 2021.
Cancer Drug Resist. 2021.
PMID: 35582030
Free PMC article.
Review.
Item in Clipboard
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer.
Fultang N, Schwab AM, McAneny-Droz S, Grego A, Rodgers S, Torres BV, Heiser D, Scherle P, Bhagwat N.
Fultang N, et al.
Front Oncol. 2024 Feb 2;14:1343004. doi: 10.3389/fonc.2024.1343004. eCollection 2024.
Front Oncol. 2024.
PMID: 38371625
Free PMC article.
Item in Clipboard
Cite
Cite